BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28640280)

  • 1. China's genomics giant to make stock-market debut.
    Cyranoski D
    Nature; 2017 Jun; 546(7659):461. PubMed ID: 28640280
    [No Abstract]   [Full Text] [Related]  

  • 2. China's bid to be a DNA superpower.
    Cyranoski D
    Nature; 2016 Jun; 534(7608):462-3. PubMed ID: 27337326
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA.Land is a framework to collect genomes and phenomes in the era of abundant genetic information.
    Yuan J; Gordon A; Speyer D; Aufrichtig R; Zielinski D; Pickrell J; Erlich Y
    Nat Genet; 2018 Feb; 50(2):160-165. PubMed ID: 29374253
    [No Abstract]   [Full Text] [Related]  

  • 4. Technology: Read the instructions.
    Scott AR
    Nature; 2016 Sep; 537(7619):S54-6. PubMed ID: 27602740
    [No Abstract]   [Full Text] [Related]  

  • 5. Businesses ready whole-genome analysis services for researchers.
    Stokes T
    Nat Med; 2011 Oct; 17(10):1161. PubMed ID: 21988969
    [No Abstract]   [Full Text] [Related]  

  • 6. Has the revolution arrived?
    Collins F
    Nature; 2010 Apr; 464(7289):674-5. PubMed ID: 20360716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Genomics revives Helicos sequencing system for China's hospitals.
    Cyranoski D
    Nat Biotechnol; 2016 Feb; 34(2):122-3. PubMed ID: 26849503
    [No Abstract]   [Full Text] [Related]  

  • 8. Separating hype from reality in the era of the affordable genome.
    Collier R
    CMAJ; 2012 Apr; 184(6):E287-8. PubMed ID: 22371514
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene sequencing leaves the laboratory.
    Hayden EC
    Nature; 2013 Feb; 494(7437):290-1. PubMed ID: 23426300
    [No Abstract]   [Full Text] [Related]  

  • 10. China embraces precision medicine on a massive scale.
    Cyranoski D
    Nature; 2016 Jan; 529(7584):9-10. PubMed ID: 26738574
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of genetic tests in the era of personalized medicine].
    Molnár JM; Magyarósi S; Németh G
    Magy Onkol; 2013 Mar; 57(1):16-20. PubMed ID: 23573517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics firms turn to other markets.
    Hayden EC
    Nature; 2010 Feb; 463(7283):859. PubMed ID: 20164890
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in clinical genomics.
    Lowe AM
    Virtual Mentor; 2012 Aug; 14(8):635-9. PubMed ID: 23351319
    [No Abstract]   [Full Text] [Related]  

  • 14. The economics of genomic medicine: insights from the IOM Roundtable on Translating Genomic-Based Research for Health.
    Feero WG; Wicklund C; Veenstra DL
    JAMA; 2013 Mar; 309(12):1235-6. PubMed ID: 23532238
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomic medicine goes mainstream.
    Conn J
    Mod Healthc; 2017 Feb; 47(8):16-19. PubMed ID: 30605578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. China buys US sequencing firm.
    Baker M
    Nature; 2012 Sep; 489(7417):485-6. PubMed ID: 23018943
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple personal genomes await.
    Venter JC
    Nature; 2010 Apr; 464(7289):676-7. PubMed ID: 20360717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Genomics and personalized medicine].
    Mooser V
    Praxis (Bern 1994); 2014 May; 103(10):567-71. PubMed ID: 24800768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese bioscience: The sequence factory.
    Cyranoski D
    Nature; 2010 Mar; 464(7285):22-4. PubMed ID: 20203579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Popping the genetics bubble.
    Collier R
    CMAJ; 2012 Apr; 184(6):637-8. PubMed ID: 22392948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.